Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	ATP6V1B2 DNAH3 ATP8B4 MYO7A MYO9A DNAH2 ABCC9 DNAH1 TRAP1 MLH3 STARD9 ATAD2B HELZ HFM1 KIFC1	4.20e-06	614	120	15	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH3 MYO7A MYO9A DNAH2 DNAH1 STARD9 KIFC1	7.21e-06	118	120	7	GO:0003774
GeneOntologyMolecularFunction	proteoglycan binding	FN1 HPSE2 HPSE LIPC PTPRC	1.36e-05	51	120	5	GO:0043394
GeneOntologyMolecularFunction	heparanase activity	HPSE2 HPSE	3.58e-05	2	120	2	GO:0030305
GeneOntologyMolecularFunction	microtubule motor activity	DNAH3 DNAH2 DNAH1 STARD9 KIFC1	6.39e-05	70	120	5	GO:0003777
GeneOntologyMolecularFunction	5-methylcytosine dioxygenase activity	TET1 TET3	1.07e-04	3	120	2	GO:0070579
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DNAH2 DNAH1	1.62e-04	18	120	3	GO:0008569
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	PLBD1 PDE7A ARSK INPP5K PTPN23 PTPN22 PTPRU DNASE2B LIPC ABHD5 ARSB PTPRC DDHD1 PNLIPRP3	3.50e-04	807	120	14	GO:0016788
GeneOntologyMolecularFunction	triacylglycerol lipase activity	LIPC ABHD5 PNLIPRP3	4.97e-04	26	120	3	GO:0004806
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH3 DNAH2 DNAH1	6.21e-04	28	120	3	GO:0051959
GeneOntologyMolecularFunction	heparan sulfate proteoglycan binding	HPSE2 LIPC PTPRC	6.90e-04	29	120	3	GO:0043395
GeneOntologyMolecularFunction	ATP hydrolysis activity	DNAH3 ATP8B4 DNAH2 ABCC9 TRAP1 MLH3 ATAD2B HFM1 KIFC1	1.39e-03	441	120	9	GO:0016887
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DNAH2 DNAH1	1.42e-03	37	120	3	GO:0045505
GeneOntologyMolecularFunction	lipase activity	PLBD1 LIPC ABHD5 DDHD1 PNLIPRP3	1.48e-03	138	120	5	GO:0016298
GeneOntologyCellularComponent	inner dynein arm	DNAH3 DNAH2 DNAH1	2.10e-05	10	119	3	GO:0036156
Domain	Glyco_hydro_79	HPSE2 HPSE	3.96e-05	2	118	2	IPR005199
Domain	Glyco_hydro_79n	HPSE2 HPSE	3.96e-05	2	118	2	PF03662
Domain	PTPc	PTPN23 PTPN22 PTPRU PTPRC	7.63e-05	36	118	4	SM00194
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH2 DNAH1	8.51e-05	14	118	3	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH2 DNAH1	8.51e-05	14	118	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DNAH2 DNAH1	8.51e-05	14	118	3	IPR013602
Domain	DHC_N2	DNAH3 DNAH2 DNAH1	8.51e-05	14	118	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH2 DNAH1	8.51e-05	14	118	3	IPR011704
Domain	MT	DNAH3 DNAH2 DNAH1	8.51e-05	14	118	3	PF12777
Domain	AAA_8	DNAH3 DNAH2 DNAH1	8.51e-05	14	118	3	PF12780
Domain	AAA_5	DNAH3 DNAH2 DNAH1	8.51e-05	14	118	3	PF07728
Domain	TYR_PHOSPHATASE_PTP	PTPN23 PTPN22 PTPRU PTPRC	1.05e-04	39	118	4	PS50055
Domain	DHC_fam	DNAH3 DNAH2 DNAH1	1.06e-04	15	118	3	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH2 DNAH1	1.06e-04	15	118	3	PF03028
Domain	Dynein_heavy_dom	DNAH3 DNAH2 DNAH1	1.06e-04	15	118	3	IPR004273
Domain	PTPase_domain	PTPN23 PTPN22 PTPRU PTPRC	1.28e-04	41	118	4	IPR000242
Domain	Y_phosphatase	PTPN23 PTPN22 PTPRU PTPRC	1.28e-04	41	118	4	PF00102
Domain	FN3	FN1 PTPRU LIFR LRRN3 PTPRC MDGA1 USH2A	1.75e-04	185	118	7	SM00060
Domain	FN3	FN1 PTPRU LIFR LRRN3 PTPRC MDGA1 USH2A	2.73e-04	199	118	7	PS50853
Domain	P-loop_NTPase	ATP6V1B2 DNAH3 MYO7A MYO9A DNAH2 ABCC9 DNAH1 SAMD9L SPATA17 STARD9 ATAD2B SRL HELZ HFM1 KIFC1	2.93e-04	848	118	15	IPR027417
Domain	Glycoside_hydrolase_SF	HPSE2 LCT HPSE MGAM2	3.49e-04	53	118	4	IPR017853
Domain	FN3_dom	FN1 PTPRU LIFR LRRN3 PTPRC MDGA1 USH2A	3.67e-04	209	118	7	IPR003961
Domain	PTPc_motif	PTPN23 PTPN22 PTPRU PTPRC	5.27e-04	59	118	4	SM00404
Domain	Tyr_Pase_cat	PTPN23 PTPN22 PTPRU PTPRC	5.27e-04	59	118	4	IPR003595
Domain	fn3	FN1 PTPRU LIFR LRRN3 PTPRC USH2A	5.75e-04	162	118	6	PF00041
Domain	Alkaline_phosphatase_core	ARSK ARSB ENPP5	9.71e-04	31	118	3	IPR017850
Domain	Alkaline_Pase-like_a/b/a	ARSK ARSB ENPP5	9.71e-04	31	118	3	IPR017849
Domain	-	ARSK ARSB ENPP5	9.71e-04	31	118	3	3.40.720.10
Domain	Tyr_Pase_AS	PTPN23 PTPN22 PTPRU PTPRC	1.18e-03	73	118	4	IPR016130
Domain	-	HPSE2 LCT HPSE	1.39e-03	35	118	3	3.20.20.80
Domain	Lipase/vitellogenin	LIPC PNLIPRP3	1.72e-03	10	118	2	IPR013818
Domain	TAG_lipase	LIPC PNLIPRP3	1.72e-03	10	118	2	IPR000734
Domain	Glyco_transf_8	GYG1 UGGT2	1.72e-03	10	118	2	PF01501
Domain	Lipase	LIPC PNLIPRP3	1.72e-03	10	118	2	PF00151
Domain	Lipase_N	LIPC PNLIPRP3	1.72e-03	10	118	2	IPR033906
Domain	Lipase_LIPH	LIPC PNLIPRP3	1.72e-03	10	118	2	IPR016272
Domain	Glyco_trans_8	GYG1 UGGT2	1.72e-03	10	118	2	IPR002495
Domain	-	GALNT13 GYG1 UGGT2 HAS2	1.73e-03	81	118	4	3.90.550.10
Domain	Glyco_hydro_catalytic_dom	HPSE2 LCT HPSE	1.77e-03	38	118	3	IPR013781
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	DNAH3 ACACA FN1 MYO7A DOCK11 VPS13C DNAH2 NBEA REV3L MIPOL1 SAMD9L FAM120C ATAD2B CFAP44	2.71e-07	736	120	14	29676528
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH3 DNAH2 DNAH1	1.39e-06	7	120	3	9256245
Pubmed	Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.	FGF18 PTPRC FGF13 MMP3 HAS2 NODAL	3.40e-06	117	120	6	22682244
Pubmed	Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.	DNAH2 PTPN22 UBASH3A IL20	8.15e-06	37	120	4	19430480
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	ACACA FN1 SEMA7A ARSK PTPN23 NDUFB9 TRAP1 FRRS1 ARSB PTPRC FAM120C MRPS24 UGGT2 AKT1 SNRPA1 CFAP44 PLXNA1	1.04e-05	1451	120	17	30550785
Pubmed	TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia.	TIMP3 MMP3	1.18e-05	2	120	2	19111539
Pubmed	Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.	PTPN22 AKT1	1.18e-05	2	120	2	22569400
Pubmed	Mutations in myosin VIIA (MYO7A) and usherin (USH2A) in Spanish patients with Usher syndrome types I and II, respectively.	MYO7A USH2A	1.18e-05	2	120	2	12112664
Pubmed	Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member.	HPSE2 HPSE	1.18e-05	2	120	2	11027606
Pubmed	TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways.	TRAP1 AKT1	1.18e-05	2	120	2	26071104
Pubmed	Immunohistochemical expression of heparanases 1 and 2 in benign tissue and in invasive neoplasia of the endometrium: a case-control study.	HPSE2 HPSE	1.18e-05	2	120	2	25423319
Pubmed	Characterization of heparanase-induced phosphatidylinositol 3-kinase-AKT activation and its integrin dependence.	HPSE AKT1	1.18e-05	2	120	2	23504323
Pubmed	Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy.	HPSE2 HPSE	1.18e-05	2	120	2	37180718
Pubmed	The Good and Bad Sides of Heparanase-1 and Heparanase-2.	HPSE2 HPSE	1.18e-05	2	120	2	32274740
Pubmed	Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.	HPSE2 HPSE	1.18e-05	2	120	2	32274741
Pubmed	Role of Tet1/3 Genes and Chromatin Remodeling Genes in Cerebellar Circuit Formation.	TET1 TET3	1.18e-05	2	120	2	26711116
Pubmed	Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers.	PTPN22 UBASH3A	1.18e-05	2	120	2	25075402
Pubmed	NADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phox.	AKT1 CYBA	1.18e-05	2	120	2	21118808
Pubmed	Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice.	HPSE FAM120C	1.18e-05	2	120	2	19096032
Pubmed	PTPN22 Acts in a Cell Intrinsic Manner to Restrict the Proliferation and Differentiation of T Cells Following Antibody Lymphodepletion.	PTPN22 PTPRC	1.18e-05	2	120	2	32047502
Pubmed	Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer.	TIMP3 MMP3	1.18e-05	2	120	2	29304854
Pubmed	MYO7A and USH2A gene sequence variants in Italian patients with Usher syndrome.	MYO7A USH2A	1.18e-05	2	120	2	25558175
Pubmed	Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease.	HPSE2 HPSE	1.18e-05	2	120	2	28387673
Pubmed	The Study of a 231 French Patient Cohort Significantly Extends the Mutational Spectrum of the Two Major Usher Genes MYO7A and USH2A.	MYO7A USH2A	1.18e-05	2	120	2	34948090
Pubmed	Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes.	TET1 TET3	1.18e-05	2	120	2	26703470
Pubmed	Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis.	TET1 TET3	1.18e-05	2	120	2	26294212
Pubmed	Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.	TIMP3 MMP3	1.18e-05	2	120	2	23872201
Pubmed	Characterisation of microvascular abnormalities using OCT angiography in patients with biallelic variants in USH2A and MYO7A.	MYO7A USH2A	1.18e-05	2	120	2	31266775
Pubmed	Decidual heparanase activity is increased during pregnancy in the baboon (Papio anubis) and in in vitro decidualization of human stromal cells.	HPSE2 HPSE	1.18e-05	2	120	2	17989358
Pubmed	Expression of heparanase isoforms in intervertebral discs classified according to Pfirrmann grading system for disc degeneration.	HPSE2 HPSE	1.18e-05	2	120	2	23370684
Pubmed	Heparanase induces Akt phosphorylation via a lipid raft receptor.	HPSE AKT1	1.18e-05	2	120	2	17689495
Pubmed	CLINICAL PRESENTATION AND DISEASE COURSE OF USHER SYNDROME BECAUSE OF MUTATIONS IN MYO7A OR USH2A.	MYO7A USH2A	1.18e-05	2	120	2	27828912
Pubmed	Crosstalk between tumor cells and lymphocytes modulates heparanase expression.	HPSE2 HPSE	1.18e-05	2	120	2	30922347
Pubmed	Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma.	HPSE2 HPSE	1.18e-05	2	120	2	36980254
Pubmed	Novel mutations in MYO7A and USH2A in Usher syndrome.	MYO7A USH2A	1.18e-05	2	120	2	15823922
Pubmed	Mutations in HPSE2 cause urofacial syndrome.	HPSE2 HPSE	1.18e-05	2	120	2	20560210
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DNAH2 DNAH1	1.42e-05	14	120	3	9373155
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	SEMA7A PTPRU LRRN3 MDGA1 PLXNA1	1.65e-05	91	120	5	28558017
Pubmed	Tet proteins influence the balance between neuroectodermal and mesodermal fate choice by inhibiting Wnt signaling.	TET1 NODAL TET3	1.77e-05	15	120	3	27930333
Pubmed	Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).	LIPC TIMP3 MMP3	1.77e-05	15	120	3	20385826
Pubmed	DNA dioxygenases Tet2/3 regulate gene promoter accessibility and chromatin topology in lineage-specific loci to control epithelial differentiation.	TET1 DLX3 TET3	1.77e-05	15	120	3	36630508
Pubmed	The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1+ hematoendothelial progenitors.	FN1 PTPRC HAS2	2.17e-05	16	120	3	33454424
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	CAMK1D ABCC9 HPSE2 PTPN22 GALNT13 RADIL LIPC ATAD2B MRPS24 SRL HAS2 NIPBL	2.61e-05	814	120	12	23251661
Pubmed	Thyroid hormone regulates fibronectin expression through the activation of the hypoxia inducible factor 1.	FN1 AKT1	3.53e-05	3	120	2	28974422
Pubmed	Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter.	TET1 TET3	3.53e-05	3	120	2	24194590
Pubmed	TET proteins in malignant hematopoiesis.	TET1 TET3	3.53e-05	3	120	2	19923888
Pubmed	Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.	TET1 TET3	3.53e-05	3	120	2	21778364
Pubmed	Tet family proteins and 5-hydroxymethylcytosine in development and disease.	TET1 TET3	3.53e-05	3	120	2	22569552
Pubmed	The Genetics of Usher Syndrome in the Israeli and Palestinian Populations.	MYO7A USH2A	3.53e-05	3	120	2	29490346
Pubmed	Kinase AKT1 negatively controls neutrophil recruitment and function in mice.	PTPRC AKT1	3.53e-05	3	120	2	23904165
Pubmed	SRY‑related HMG box‑2 role in anaplastic thyroid cancer aggressiveness is related to the fibronectin 1 and PI3K/AKT pathway.	FN1 AKT1	3.53e-05	3	120	2	31922212
Pubmed	circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer.	ACACA STAT2	3.53e-05	3	120	2	36328987
Pubmed	Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells.	PTPN22 ITK	3.53e-05	3	120	2	19714314
Pubmed	Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.	TET1 TET3	3.53e-05	3	120	2	23548903
Pubmed	Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression.	CCNG1 AKT1	3.53e-05	3	120	2	22271581
Pubmed	5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function.	TET1 TET3	3.53e-05	3	120	2	34919053
Pubmed	Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer.	TET1 TET3	3.53e-05	3	120	2	26207381
Pubmed	Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling.	HPSE2 HPSE	3.53e-05	3	120	2	31537875
Pubmed	Autoimmunity-associated protein tyrosine phosphatase PEP negatively regulates IFN-α receptor signaling.	PTPN22 PTPRC	3.53e-05	3	120	2	26077719
Pubmed	Effect of aging on 5-hydroxymethylcytosine in brain mitochondria.	TET1 TET3	3.53e-05	3	120	2	22445327
Pubmed	Loss of Tet enzymes compromises proper differentiation of embryonic stem cells.	TET1 TET3	3.53e-05	3	120	2	24735881
Pubmed	Serum Levels of TIMP-3, LIPC, IER3, and SLC16A8 in CFH-Negative AMD Cases.	LIPC TIMP3	3.53e-05	3	120	2	27966779
Pubmed	Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification.	TET1 TET3	3.53e-05	3	120	2	20639862
Pubmed	Ten-Eleven Translocation Genes are Downregulated in Endometriosis.	TET1 TET3	3.53e-05	3	120	2	26917261
Pubmed	Alternation of ten-eleven translocation 1, 2, and 3 expression in eutopic endometrium of women with endometriosis-associated infertility.	TET1 TET3	3.53e-05	3	120	2	30130982
Pubmed	Regulation of DNA methylation signatures on NF-κB and STAT3 pathway genes and TET activity in cigarette smoke extract-challenged cells/COPD exacerbation model in vitro.	TET1 TET3	3.53e-05	3	120	2	32342329
Pubmed	PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.	PTPN22 PTPRC	3.53e-05	3	120	2	19299707
Pubmed	Expression of TET and 5-HmC in Trophoblast Villi of Women with Normal Pregnancy and with Early Pregnancy Loss.	TET1 TET3	3.53e-05	3	120	2	30074219
Pubmed	Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms.	TET1 TET3	3.53e-05	3	120	2	29531217
Pubmed	Selective targeting of TET catalytic domain promotes somatic cell reprogramming.	TET1 TET3	3.53e-05	3	120	2	32024762
Pubmed	Tet Enzymes Regulate Telomere Maintenance and Chromosomal Stability of Mouse ESCs.	TET1 TET3	3.53e-05	3	120	2	27184841
Pubmed	Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.	TET1 TET3	3.53e-05	3	120	2	19372391
Pubmed	Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses.	PTPRC CNR2	3.53e-05	3	120	2	22048769
Pubmed	Mechanisms of TET protein-mediated DNA demethylation and its role in the regulation of mouse development.	TET1 TET3	3.53e-05	3	120	2	25608811
Pubmed	Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.	TET1 TET3	3.53e-05	3	120	2	19420352
Pubmed	Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway.	HPSE AKT1	3.53e-05	3	120	2	23442498
Pubmed	Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation.	TET1 TET3	3.53e-05	3	120	2	28218476
Pubmed	Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women.	MMP3 CYBA	3.53e-05	3	120	2	15172469
Pubmed	Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.	TET1 TET3	3.53e-05	3	120	2	24958354
Pubmed	T/B lineage choice occurs prior to intrathymic Notch signaling.	FN1 PTPRC	3.53e-05	3	120	2	15845899
Pubmed	One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.	TET1 TET3	3.53e-05	3	120	2	23643243
Pubmed	Targeted next generation sequencing in Italian patients with Usher syndrome: phenotype-genotype correlations.	MYO7A USH2A	3.53e-05	3	120	2	29142287
Pubmed	Stage-specific regulation of DNA methylation by TET enzymes during human cardiac differentiation.	TET1 TET3	3.53e-05	3	120	2	34879277
Pubmed	Oxygen regulation of TET enzymes.	TET1 TET3	3.53e-05	3	120	2	33410283
Pubmed	Differential expression of ten-eleven translocation genes in endometrial cancers.	TET1 TET3	3.53e-05	3	120	2	28349832
Pubmed	CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway.	AKT1 CNR2	3.53e-05	3	120	2	27634891
Pubmed	Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.	TIMP3 MMP3	3.53e-05	3	120	2	11827795
Pubmed	Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.	TIMP3 TET1	3.53e-05	3	120	2	32542727
Pubmed	Heparanase-Induced Activation of AKT Stabilizes β-Catenin and Modulates Wnt/β-Catenin Signaling during Herpes Simplex Virus 1 Infection.	HPSE AKT1	3.53e-05	3	120	2	34749529
Pubmed	Identification of genetic factors and development of genetic risk diagnosis systems for cardiovascular diseases and stroke.	MMP3 CYBA	7.05e-05	4	120	2	16998253
Pubmed	[Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease].	TIMP3 MMP3	7.05e-05	4	120	2	22888638
Pubmed	Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine.	TET1 TET3	7.05e-05	4	120	2	21321204
Pubmed	Paradoxical association of TET loss of function with genome-wide DNA hypomethylation.	TET1 TET3	7.05e-05	4	120	2	31371502
Pubmed	Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism.	MYO7A USH2A	7.05e-05	4	120	2	18463160
Pubmed	MMP-2, -3 and TIMP-2, -3 polymorphisms in colorectal cancer in a Chinese Han population: A case-control study.	TIMP3 MMP3	7.05e-05	4	120	2	31887330
Pubmed	Activation-induced cytidine deaminase alters the subcellular localization of Tet family proteins.	TET1 TET3	7.05e-05	4	120	2	23028748
Pubmed	Deterministic Somatic Cell Reprogramming Involves Continuous Transcriptional Changes Governed by Myc and Epigenetic-Driven Modules.	TET1 TET3	7.05e-05	4	120	2	30554962
Pubmed	Ultraviolet B-induced matrix metalloproteinase-1 and -3 secretions are mediated via PTEN/Akt pathway in human dermal fibroblasts.	AKT1 MMP3	7.05e-05	4	120	2	16972255
Pubmed	Tissue inhibitor of metalloproteinases 3 regulates extracellular matrix--cell signaling during bronchiole branching morphogenesis.	FN1 TIMP3	7.05e-05	4	120	2	16890932
Pubmed	Phosphorylation of TET proteins is regulated via O-GlcNAcylation by the O-linked N-acetylglucosamine transferase (OGT).	TET1 TET3	7.05e-05	4	120	2	25568311
GeneFamily	Fibronectin type III domain containing	FN1 PTPRU LIFR LRRN3 PTPRC ELFN1 USH2A	8.80e-06	160	83	7	555
GeneFamily	Dyneins, axonemal	DNAH3 DNAH2 DNAH1	6.06e-05	17	83	3	536
GeneFamily	Olfactory receptors, family 56	OR56A5 OR56A4	7.34e-04	9	83	2	167
GeneFamily	Zinc fingers CXXC-type	TET1 TET3	1.33e-03	12	83	2	136
GeneFamily	Protein tyrosine phosphatases, non-receptor type	PTPN23 PTPN22	3.04e-03	18	83	2	812
GeneFamily	Sulfatases	ARSK ARSB	3.04e-03	18	83	2	410
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRU PTPRC	4.13e-03	21	83	2	813
GeneFamily	Lipases\|Arylacetamide deacetylase family	LIPC PNLIPRP3	4.53e-03	22	83	2	464
GeneFamily	DNA polymerases	REV3L POLA2	4.95e-03	23	83	2	535
GeneFamily	Cyclins	CCNG1 CCNI	7.28e-03	28	83	2	473
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MYO7A NBEA	7.80e-03	29	83	2	396
Coexpression	GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP	ATP8B4 DOCK11 ITK FRRS1 SAMD9L CENPM TET1 PLXNA1	3.66e-06	199	119	8	M5604
Coexpression	GABRIELY_MIR21_TARGETS	MYO9A NBEA REV3L CCNG1 LIFR TIMP3 ATAD2B TET1 NIPBL	7.13e-06	289	119	9	M2196
Coexpression	E2F1_UP.V1_UP	STIL PTPRU POLA2 SOCS2 RHBDL3 KIFC1 CYBA	2.49e-05	188	119	7	M2632
Coexpression	GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN	SYCP2L LIPC SPATA17 SLC45A3 TET1 SCNN1G MMP3	3.58e-05	199	119	7	M9434
Coexpression	GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP	CAMK1D DOCK11 DTNB VPS13C ATAD2B EXOC2 RASGRP2	3.58e-05	199	119	7	M9238
Coexpression	GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP	PLBD1 PDE7A DTNB SAMD9L METTL18 ENPP5 MMP3	3.69e-05	200	119	7	M9342
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1	PDE7A DOCK11 PTPN22 REV3L UBASH3A ITK SAMD9L TET1 FGF13 CNR2	1.48e-05	336	115	10	GSM538413_500
ToppCell	severe-Myeloid-Eosinophils\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYCP2L CAMK1D SEMA7A IDO1 SOCS2 SLC45A3 CNR2	4.04e-07	170	120	7	863f0266d5837cdbc3e09a3fe6a99dd3e6261674
ToppCell	severe-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYCP2L CAMK1D SEMA7A IDO1 SOCS2 SLC45A3 CNR2	5.93e-07	180	120	7	ac03812b1409435c55d323a7516deeac82bd3509
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDE7A PTPN22 UBASH3A ITK LRRN3 PTPRC RASGRP2	8.83e-07	191	120	7	133864ec1e89f97a82c3bb01d2a3c658397fefaf
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DOCK11 PTPRU LCT HPSE ELFN1 RASGRP2	9.97e-07	122	120	6	eae9d94f8510ac0f434942451d55c7260977b178
ToppCell	Fetal_29-31_weeks-Immune\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ATP8B4 CAMK1D DOCK11 PTPN22 ITK PTPRC CYBA	1.12e-06	198	120	7	5dff131356b8c22743bd27b2b21f86ee6e4a0a0d
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	VPS13C STAT2 SAMD9L PTPRC ATAD2B HELZ NIPBL	1.20e-06	200	120	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE7A CAMK1D DOCK11 UBASH3A ITK PTPRC RASGRP2	1.20e-06	200	120	7	e0cec0a844b7c1f8edee4c005af27766754e470a
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP8B4 PTPN22 UBASH3A ITK ARSB PTPRC	4.48e-06	158	120	6	5d926be5a0ebe8257cd552afa7844171f9ff01c0
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HPSE2 RADIL TET1 HFM1 FGF13 MSS51	4.81e-06	160	120	6	778faada072e3abfa76a9a06fd4885fb63de7902
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DOCK11 PTPRU HPSE TIMP3 ELFN1 RASGRP2	4.99e-06	161	120	6	bf70be1de418615b5442ec684552551edaf1f072
ToppCell	facs-Lung-nan-3m-Lymphocytic-Natural_Killer\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE7A DOCK11 PTPN22 ITK ARSB PTPRC	4.99e-06	161	120	6	ae1cee34361dde9964581cca99a29578c3b3bd99
ToppCell	facs-Lung-nan-3m-Lymphocytic-NK_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE7A DOCK11 PTPN22 ITK ARSB PTPRC	4.99e-06	161	120	6	33de3e8b3238fcfc66dfbf89a913a07d464d6c35
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLBD1 ATP8B4 PTPN22 FRRS1 PTPRC CENPM	5.35e-06	163	120	6	8028636632c168dc50731d0ebecaf88a70daf81d
ToppCell	368C-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	IDO1 DNAH2 SOCS2 USP54 TMEM178B PLXNA1	5.74e-06	165	120	6	9d2bdc42c13c8c2a68889bec8612a1ce56f659fa
ToppCell	facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLBD1 ATP8B4 FN1 HPSE USH2A RASGRP2	5.74e-06	165	120	6	ab6ed7e30096c418e7be2d5eec33feeddd1387d9
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 PDE7A PTPN22 UBASH3A ITK PTPRC	6.37e-06	168	120	6	dc1143bd8db70c490167d73a525fd9b783eba960
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 PDE7A PTPN22 UBASH3A ITK PTPRC	6.37e-06	168	120	6	a75d63ae8ad64b5560853775f6df398feb314ce8
ToppCell	control-Myeloid-Eosinophils\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYCP2L ATP8B4 SEMA7A SOCS2 SLC45A3 CNR2	7.05e-06	171	120	6	82f736c33ed96c0865618e8f8eb82a5487126bdc
ToppCell	mild-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYCP2L CAMK1D SEMA7A SOCS2 SLC45A3 CNR2	7.05e-06	171	120	6	5c8198182495bda7a826e9d80aa467f4eb1094ec
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLBD1 PTPN22 ITK LIPC PTPRC CNR2	7.29e-06	172	120	6	3ffe721f62c0d20c1d765ecb15ed4e1aa88099f7
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLBD1 PTPN22 ITK LIPC PTPRC CNR2	7.29e-06	172	120	6	2bbe3f601a56577d200aa7ba7031f7c19b988cc1
ToppCell	droplet-Kidney-nan-3m-Lymphocytic\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLBD1 ATP8B4 CAMK1D PTPN22 ITK PTPRC	7.78e-06	174	120	6	0e541581df2d4249270b28ceded6298329013580
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDE7A IPO7 ARSK MLH3 TIMP3 SLC45A3	8.04e-06	175	120	6	711ace94fa9a763c6ae48171a690953f25deebe4
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP8B4 UBASH3A ITK SRL CNR2 KIFC1	8.04e-06	175	120	6	8958c5c30437d20a4abd70d7527990f7e2a68b93
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE7A PTPN22 UBASH3A ITK PTPRC RASGRP2	8.31e-06	176	120	6	9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575
ToppCell	facs-Aorta\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA7A PTPRU TECTA DYSF LIFR TIMP3	8.31e-06	176	120	6	0b3491451be02c18a16cdb875645be47eb867a7f
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE7A PTPN22 UBASH3A ITK PTPRC RASGRP2	8.31e-06	176	120	6	bb41e9478373726eb460af764de0277b2d09928e
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE7A PTPN22 UBASH3A ITK PTPRC RASGRP2	8.31e-06	176	120	6	ea27e18407b8a13e8212830da859efeb8f158690
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE7A PTPN22 UBASH3A ITK PTPRC RASGRP2	8.31e-06	176	120	6	bfbab3c5b738b3b0b1540f2059d0245fbd8c0031
ToppCell	droplet-Tongue-nan-24m-Myeloid-basal_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 PTPN22 UBASH3A ITK PTPRC CYBA	8.86e-06	178	120	6	9423e209de94d26e96117581c95dc069850225d3
ToppCell	facs-Liver-Non-hepatocytes-24m-Lymphocytic-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE7A PTPN22 UBASH3A ITK PTPRC CYBA	8.86e-06	178	120	6	d26823af06913d9fe88f054a24f369531248e245
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 LIFR RADIL TIMP3 STARD9 RHBDL3	8.86e-06	178	120	6	375156ba1c7b8592bf733c75f24968161f7cfa09
ToppCell	Endothelial-A-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	NLGN1 FGF18 LIFR TIMP3 HFM1 HAS2	8.86e-06	178	120	6	2f2602b9305d55f25afa9861dd6c6347ae179337
ToppCell	LPS-antiTNF-Lymphocytic_NKT\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE7A PTPN22 UBASH3A ITK PTPRC RASGRP2	9.15e-06	179	120	6	ecea75c568911ff56939c9f67ab901497bd4356c
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ATP8B4 SEMA7A IDO1 PTPN22 PTPRC CNR2	9.15e-06	179	120	6	9fc44637c9a7551fd47b8533e45a9c199e164a95
ToppCell	NS-moderate-d_0-4-Lymphoid-CTL\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DOCK11 PTPN22 ITK PTPRC MSS51 RASGRP2	9.75e-06	181	120	6	7fb3c1d29c542a3cea7fa654432d501d82df138f
ToppCell	facs-Marrow-T-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 VPS13C ITK LIFR DNASE2B ARSB	9.75e-06	181	120	6	7286700396676fdc41d9723979b8b408177aceb9
ToppCell	10x5'-bone_marrow-Mast-Mast_cell_lympho\|bone_marrow / Manually curated celltypes from each tissue	ATP8B4 SEMA7A SOCS2 ABHD5 SLC45A3 TET3	9.75e-06	181	120	6	56fa77ae31f3b7de6e441a439c33a11353b6573a
ToppCell	facs-Liver-Non-hepatocytes-24m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE7A PTPN22 UBASH3A ITK PTPRC CYBA	1.07e-05	184	120	6	9dc7c8c0b8a74e09df51f24f0151c494cd1ea6ad
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP6V1B2 DOCK11 DNASE2B ABHD5 PTPRC C8B	1.07e-05	184	120	6	840fac463665ed18752f402f7d1ef2e5052bdf74
ToppCell	T_cells-Resident_memory_CD8+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PDE7A MYO7A PTPN22 UBASH3A STARD9 GYG1	1.07e-05	184	120	6	e04cabff33a8e36967622ec3e5b37b89afa7e148
ToppCell	control-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYCP2L ATP8B4 SEMA7A SOCS2 SLC45A3 CNR2	1.07e-05	184	120	6	fad517d047e8eaeaa5bd4f311d770880568dd13c
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 PTPRU UBASH3A ABHD5 ARSB ENPP5	1.10e-05	185	120	6	53854a9ec87c24c360541c83d86d8fafb303ad58
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 PTPRU UBASH3A ABHD5 ARSB ENPP5	1.10e-05	185	120	6	a61fc7a3700a1efcf640bef7680c0443ee148a46
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	ATP8B4 SEMA7A VPS13C PTPRC DDHD1 ZBTB40	1.10e-05	185	120	6	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	COVID-19-lung-B_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE7A CAMK1D DOCK11 PTPRC CNR2 RASGRP2	1.10e-05	185	120	6	e8f1ad580f19705b5ca1d7d8867b2125f4891684
ToppCell	droplet-Tongue-nan-24m-Myeloid-Langerhans_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA7A DNAH2 PTPN22 ITK PTPRC CYBA	1.14e-05	186	120	6	3e16781b9646de971d953da2c49d4210a4c23fe3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE7A PTPN22 UBASH3A ITK PTPRC RASGRP2	1.14e-05	186	120	6	9d576dce2c5deefef1adda16c6da7055c8d57f8f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE7A PTPN22 UBASH3A ITK PTPRC RASGRP2	1.14e-05	186	120	6	bd3bd022b575d9b0ef90d50a5cb874085a827b77
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	ATP8B4 SEMA7A VPS13C PTPRC DDHD1 ZBTB40	1.14e-05	186	120	6	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	droplet-Tongue-nan-24m-Myeloid\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA7A DNAH2 PTPN22 ITK PTPRC CYBA	1.14e-05	186	120	6	298ea4c7f61df65537dfef171ca81d4e976d89c5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE7A PTPN22 UBASH3A ITK PTPRC RASGRP2	1.14e-05	186	120	6	924cc357b4c4ce8e9b05773bdab544f0b65474cc
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PTPN22 UBASH3A ITK PTPRC CNR2 RASGRP2	1.17e-05	187	120	6	9d298f43ae81d72091b31aaa6df41046d4aa31c5
ToppCell	droplet-Skin-nan-21m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 PTPN22 HPSE ITK PTPRC CYBA	1.17e-05	187	120	6	38d7b19fde6811f5fbf548b2464486b197476dc6
ToppCell	droplet-Skin-nan-21m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 PTPN22 HPSE ITK PTPRC CYBA	1.17e-05	187	120	6	ea33a5bd60b7f5f6d5b07a7f06a5a56395943641
ToppCell	droplet-Skin-nan-21m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 PTPN22 HPSE ITK PTPRC CYBA	1.17e-05	187	120	6	1dbc2c0ab85033e5de776bbfdb73ebd3a50d2cc6
ToppCell	Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	PLBD1 FN1 DOCK11 SAMD9L ARSB PTPRC	1.25e-05	189	120	6	c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCell	T_cells-GZMK+_CD8+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PDE7A PTPN22 UBASH3A PTPRC GYG1 EXOC2	1.25e-05	189	120	6	e2ca075aedf7c370ab4ede6272254ffd06cbcdec
ToppCell	facs-Trachea-nan-3m-Lymphocytic\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN22 STIL UBASH3A ITK PTPRC KIFC1	1.32e-05	191	120	6	89eb4e30052d0d4a2952157ca743291900ce8de2
ToppCell	facs-Trachea-nan-3m-Lymphocytic-T_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN22 STIL UBASH3A ITK PTPRC KIFC1	1.32e-05	191	120	6	0bf575eba311745fb75f9523f7fc81f73848e25d
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PTPN22 STIL UBASH3A ITK PTPRC KIFC1	1.32e-05	191	120	6	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	ATP8B4 VPS13C ITK PTPRC DDHD1 ZBTB40	1.32e-05	191	120	6	9454f642c3621370fa23640b631301346b300950
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LRCH2 FN1 HPSE2 TIMP3 STARD9 SRL	1.32e-05	191	120	6	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	facs-Trachea-nan-3m-Lymphocytic-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN22 STIL UBASH3A ITK PTPRC KIFC1	1.32e-05	191	120	6	c57df363e3a6e61d2bdca1955330f1899b964267
ToppCell	(1)_Osterolineage_cells-(10)_OLC-1\|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	SEMA7A ABCC9 SOCS2 LIFR ENPP5 RASGRP2	1.32e-05	191	120	6	78ad7c555409ce1391bce406bc0f3ef575329ece
ToppCell	tumor_Lung-Myeloid_cells-Alveolar_Mac\|tumor_Lung / Location, Cell class and cell subclass	PLBD1 FN1 DNASE2B ABHD5 C8B CYBA	1.36e-05	192	120	6	44eda67501e69799c5981be602c143d12f5f222f
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP6V1B2 DOCK11 DNASE2B PTPRC CCNI CYBA	1.36e-05	192	120	6	b9d6cf6068ffa104968f4944cbf8af6faa2b8942
ToppCell	LV-08._Macrophage\|LV / Chamber and Cluster_Paper	ATP8B4 CAMK1D DOCK11 PTPRC TET3 CYBA	1.36e-05	192	120	6	7be12d580aaf2f2f1562203fcad3a44639b8c5a6
ToppCell	NS-moderate-d_0-4-Lymphoid\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DOCK11 PTPN22 ITK PTPRC RHBDL3 RASGRP2	1.36e-05	192	120	6	905217dcfc843d3469e9e71bd33707863b14cc82
ToppCell	IPF-Endothelial-VE_Arterial\|IPF / Disease state, Lineage and Cell class	IDO1 NLGN1 FGF18 SOCS2 LIFR TIMP3	1.40e-05	193	120	6	bf83b1fe9d38408f30eee4eb634341c04ef82791
ToppCell	COVID-19-kidney-T-cells-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE7A DOCK11 PTPN22 UBASH3A ITK PTPRC	1.40e-05	193	120	6	5b84fa640cf30dea55fde53b810f850ff946d253
ToppCell	RA-08._Macrophage\|RA / Chamber and Cluster_Paper	ATP8B4 DOCK11 PTPN22 PTPRC FGF13 TET3	1.44e-05	194	120	6	ac26e5c71d5069622de72fa25a9c920887ac2c19
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SEMA7A PTPRC CENPM CNR2 RASGRP2 CYBA	1.49e-05	195	120	6	e3df097e894b96b7d23db35bd527a8de6a055e52
ToppCell	COVID-19-kidney-Proliferating_T_cell\|kidney / Disease (COVID-19 only), tissue and cell type	PTPN22 STIL UBASH3A ITK PTPRC KIFC1	1.49e-05	195	120	6	7e05e56f8d0a7a052830c7db12b10dace7d10760
ToppCell	Macrophages-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	DOCK11 PTPN22 ABHD5 PTPRC DDHD1 C8B	1.49e-05	195	120	6	2af46e87947c16a7c2c367637e606cfbb8a78528
ToppCell	facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA7A MYO7A PTPRU DYSF LIFR TIMP3	1.49e-05	195	120	6	3969b8d5fcec8ef1831531a781f7bbcebab5a4ba
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ANO9 PDE7A UBASH3A ITK SOCS2 LRRN3	1.49e-05	195	120	6	22191d361af136942508f1553ff41a626ed982ad
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DOCK11 PTPRU HPSE ELFN1 RASGRP2	1.51e-05	115	120	5	ac73aa06e617ed791c6ae9e38189bac74188c27b
ToppCell	(7)_Epithelial-I_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	GALNT13 LIPC TIMP3 SCNN1G MDGA1 PLXNA1	1.53e-05	196	120	6	150554fa06868d29b0608189862eef6505ba757f
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP8B4 MYO7A DOCK11 PTPN22 ITK PTPRC	1.58e-05	197	120	6	b803c07072a7860497d07a3be358a28a24359cbf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ATP8B4 CAMK1D DOCK11 PTPN22 ITK PTPRC	1.58e-05	197	120	6	c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a
ToppCell	COVID-19-kidney-T-cells-1\|kidney / Disease (COVID-19 only), tissue and cell type	PDE7A DOCK11 PTPN22 UBASH3A ITK PTPRC	1.58e-05	197	120	6	9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLBD1 FN1 DOCK11 DNASE2B ABHD5 CYBA	1.58e-05	197	120	6	2e622d75fb45cfa80f78e1880ad056a50709895a
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-SELL+_CD8_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE7A UBASH3A ITK LRRN3 PTPRC RASGRP2	1.62e-05	198	120	6	0dac00a64fe08ec6669af3ddd4b82413b673233d
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLBD1 DOCK11 SAMD9L ABHD5 PTPRC DDHD1	1.62e-05	198	120	6	e125eb8aa57c172e5518874da1bd25998292f5e2
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK11 VPS13C ABCC9 LIFR PTPRC CCNI	1.62e-05	198	120	6	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLBD1 DOCK11 SAMD9L ABHD5 PTPRC DDHD1	1.62e-05	198	120	6	0baeb8e2c199ff10bb5c829c523546af3c9227c1
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK11 VPS13C ABCC9 LIFR PTPRC CCNI	1.62e-05	198	120	6	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PLBD1 ATP6V1B2 ABHD5 PTPRC GYG1 CYBA	1.62e-05	198	120	6	9b29232c8b4dcbd81f450f47c3f79bf26c8fb583
ToppCell	Control\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PDE7A CAMK1D PTPRC CCNI CNR2 RASGRP2	1.62e-05	198	120	6	73694b6109c1f6878b6b5997e434bbc3cec1dc70
ToppCell	Control_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK11 PTPN22 UBASH3A ITK PTPRC RASGRP2	1.62e-05	198	120	6	9663cf0c8296d3a7b0329cb725ccceeea7849cbc
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLBD1 FN1 DOCK11 DNASE2B ABHD5 CYBA	1.62e-05	198	120	6	1774dd36315a04c4cdcef2cc674204e4ab9c175b
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK11 VPS13C ABCC9 LIFR PTPRC CCNI	1.62e-05	198	120	6	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	Control_saline-Hematopoietic_Lymphocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK11 PTPN22 UBASH3A ITK PTPRC RASGRP2	1.62e-05	198	120	6	d442b35768fe0f75a971784af23400d5d0c7530a
ToppCell	10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PLBD1 DYSF ABHD5 PTPRC GYG1 CYBA	1.67e-05	199	120	6	7cbd98dd10c91584dee04593910031e90c1340b8
ToppCell	Control_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT\|Control_saline / Treatment groups by lineage, cell group, cell type	ATP8B4 DOCK11 PTPN22 UBASH3A ITK PTPRC	1.67e-05	199	120	6	2d7ebb9642f6fe0afd5e3fdc711ded54b73acd11
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-SELL+_CD4_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE7A UBASH3A ITK LRRN3 PTPRC RASGRP2	1.67e-05	199	120	6	b01328a80db5bb088c44564cea0f6729b1a9805b
ToppCell	LPS_anti-TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDE7A PTPN22 UBASH3A ITK PTPRC RASGRP2	1.67e-05	199	120	6	618dc6425bb7b84d3b2de7cf8ecb41549a255718
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE7A DOCK11 UBASH3A ITK PTPRC RASGRP2	1.67e-05	199	120	6	6150b272313d3fbf5ddcb3a8d51862d368220fe2
ToppCell	15-Trachea-Immune-Hematopoietic,_T_Cells\|Trachea / Age, Tissue, Lineage and Cell class	PTPN22 UBASH3A ITK LRRN3 PTPRC RASGRP2	1.67e-05	199	120	6	d5dcf7b4f58a075a7f729165556f7666e6b4c104
Drug	Etomidate [33125-97-2]; Up 200; 16.4uM; HL60; HT_HG-U133A	PCDHGA10 FGF18 STAT2 SOCS2 MLH3 MMP3 TRAPPC14 PLXNA1 RASGRP2	8.61e-07	196	118	9	2958_UP
Disease	Autism Spectrum Disorders	LRRN3 DDHD1 TET1 USH2A TET3	2.29e-05	85	117	5	C1510586
Disease	hearing impairment	MYO7A TECTA ABHD5 ARSB USH2A	4.55e-05	98	117	5	C1384666
Disease	Usher syndrome type 2	MYO7A USH2A	4.66e-05	3	117	2	C0339534
Disease	Usher syndrome (is_implicated_in)	MYO7A USH2A	9.30e-05	4	117	2	DOID:0050439 (is_implicated_in)
Disease	Usher Syndrome, Type II	MYO7A USH2A	1.55e-04	5	117	2	C1568249
Disease	urate measurement	SYCP2L DNAH3 MYO9A DYSF DNAH1 MIPOL1 TRAP1 LIPC SPATA17 UGGT2 HFM1 RASGRP2	2.34e-04	895	117	12	EFO_0004531
Disease	focal segmental glomerulosclerosis (implicated_via_orthology)	MYO9A LIPC	3.23e-04	7	117	2	DOID:1312 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	CATSPERE FN1 IDO1 INPP5K TECTA DYSF HPSE PTPRC AKT1 USP54 MMP3 NIPBL CNR2	3.43e-04	1074	117	13	C0006142
Disease	type 1 diabetes mellitus	DNAH2 HPSE2 PTPN22 UBASH3A PTPRC EXOC2	4.19e-04	242	117	6	MONDO_0005147
Disease	osteoarthritis, spine, body mass index	NLGN1 ABHD5	4.30e-04	8	117	2	EFO_0004340, EFO_1000787
Disease	Colorectal Carcinoma	DNAH3 ACACA FN1 FOLH1 PTPRU LIFR MLH3 SCNN1G AKT1 NODAL	4.95e-04	702	117	10	C0009402
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	PTPN22 UBASH3A PTPRC EXOC2 TET3	5.96e-04	170	117	5	EFO_0000685, EFO_0007791, EFO_0007837
Disease	phosphatidylethanolamine measurement	SYCP2L ANO9 ABCC9 LIPC USH2A	6.45e-04	173	117	5	EFO_0010228
Disease	lymphocyte count	ACACA FN1 PCDHGA10 RRN3P2 PSMD3 PTPN22 UBASH3A LIPC PTPRC SLC45A3 ATAD2B HELZ HFM1 FGF13 CNR2	6.86e-04	1464	117	15	EFO_0004587
Disease	coronary artery disease (is_implicated_in)	PTPN22 LIPC MMP3 CYBA	6.87e-04	100	117	4	DOID:3393 (is_implicated_in)
Disease	eosinophil count	DNAH3 XPNPEP1 DYSF UBASH3A ITK MIPOL1 LIPC PTPRC TMEM232 SLC45A3 ZBTB40 HFM1 EXOC2 TET3 CNR2	8.09e-04	1488	117	15	EFO_0004842
Disease	Ciliopathies	MYO7A SCNN1G NODAL USH2A	9.81e-04	110	117	4	C4277690
Disease	sitting height ratio	ATAD2B EXOC2 MDGA1	1.10e-03	51	117	3	EFO_0007118
Disease	pain	HPSE2 NLGN1 MIPOL1 ATAD2B TMEM178B	1.13e-03	196	117	5	EFO_0003843
Disease	Cakut	LIFR TRAP1	1.18e-03	13	117	2	C1968949
Disease	Genetic chronic primary adrenal insufficiency	PTPN22 UBASH3A	1.18e-03	13	117	2	Orphanet_101960
Disease	ovarian carcinoma (is_implicated_in)	SOCS2 CCNG1	1.58e-03	15	117	2	DOID:4001 (is_implicated_in)
Disease	schizophrenia (implicated_via_orthology)	LRRN3 ELFN1 AKT1	2.52e-03	68	117	3	DOID:5419 (implicated_via_orthology)
Disease	glomerulonephritis (is_marker_for)	FN1 MMP3	2.55e-03	19	117	2	DOID:2921 (is_marker_for)
Disease	Schizophrenia	FOLH1 NLGN1 SOCS2 LIFR TET1 AKT1 MMP3 MSS51 MDGA1 CNR2	2.74e-03	883	117	10	C0036341
Disease	Autosomal Recessive Primary Microcephaly	STIL TRAPPC14	3.42e-03	22	117	2	C3711387
Disease	anxiety disorder (implicated_via_orthology)	NODAL CNR2	3.42e-03	22	117	2	DOID:2030 (implicated_via_orthology)
Disease	idiopathic pulmonary fibrosis (is_marker_for)	AKT1 MMP3	3.73e-03	23	117	2	DOID:0050156 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VLQNSRHPFLTALKY	AKT1	201	P31749
YSLDQKLHSIINYPK	ARSK	461	Q6UWY0
RDLAYSQLSPQYHSL	ELFN1	746	P0C7U0
LLRTYLKNLSPYINS	nan	131	Q9N2K0
LLHIYLKNLSPYINS	nan	131	Q9N2J8
ILSRSNHPKLGYSYA	ELMOD2	191	Q8IZ81
YVIEKSYLRHQPSKN	CATSPERE	726	Q5SY80
SYLRHQPSKNLRVRY	CATSPERE	731	Q5SY80
LNSVYVYRPLKHTLV	CCNI	256	Q14094
LYLTPQDYKRVSALN	ACACA	1751	Q13085
YYHNIETSNFPKLLL	ABCC9	121	O60706
NRIHTSKYNILTFLP	ATP8B4	31	Q8TF62
RPYQHSYLRSTVILV	ANO9	321	A1A5B4
KPRTIYSSYQLAALQ	DLX3	131	O60479
HKISSYRLVQPSKYS	CFAP44	1041	Q96MT7
YLILSSHQLRRKPSY	CNR2	56	P34972
ELNYSLPYDSKHQIR	PTPN22	496	Q9Y2R2
SVLRKYLGQLHYLQS	PTPN23	66	Q9H3S7
ASLHQPLYYLLSLLS	OR56A4	56	Q8NGH8
MRYSLYQSPHLLLLQ	RADIL	241	Q96JH8
QLKHSYYRITHLPTI	CCNG1	276	P51959
PTRSHKLSKNYSYVL	MDGA1	646	Q8NFP4
LNRQLHTPMYYFLSS	OR8D4	51	Q8NGM9
SLRSYHLQIVTKYIL	IDO1	341	P14902
KINTRFLLYTIHNPN	PNLIPRP3	51	Q17RR3
YIPSSQLAAKLLHIY	RASGRP2	46	Q7LDG7
KSSRHYLNIRYTLLP	MGAM2	656	Q2M2H8
IQTLRVYYSLHKSLS	MIPOL1	336	Q8TD10
RDYKIPTLITVYSHQ	MSS51	376	Q4VC12
RRRYPQIYASSHKLQ	ATAD2B	626	Q9ULI0
LLSYPNKTHPNYISI	FOLH1	116	Q04609
KTHLTYRIVNYTPDL	MMP3	111	P08254
SHVPYRNSKLTYLLQ	KIFC1	611	Q9BW19
NYYVRAVLHLLLSVP	CYBA	86	P13498
ILRDLVLSPNHQYLY	PLXNA1	486	Q9UIW2
TPSTLHDQKRYIRYL	EXOC2	346	Q96KP1
YYNPHLLLNTLENLR	IPO7	791	O95373
ESLAVKIHNILYPYR	MLH3	1166	Q9UHC1
LQSYQLSPNKHFSLR	PCDHGA10	171	Q9Y5H3
ISYAIQKGHLSPRYI	PGLYRP3	141	Q96LB9
QPFLIKTNHYLATLY	PDE7A	261	Q13946
HYKYNSRIQPIIAVA	ENPP5	306	Q9UJA9
QLRLYQLYSRTSGKH	FGF18	51	O76093
VIQYTKFHLQNTLYP	NIPBL	1336	Q6KC79
LVTRAQSPFKVYHYQ	LIPC	341	P11150
LNTYYSRIVQHKTPR	LCT	1206	P09848
YYSNLHQTFLRLLSK	METTL18	301	O95568
TRYSQKDQLYLHIGL	NLGN1	616	Q8N2Q7
TLRDKLVHQYLLQPY	HPSE2	516	Q8WWQ2
LTKSNYQSRLHDLLY	HELZ	451	P42694
TLYAINLHNVTKYLR	HPSE	451	Q9Y251
DHYTNLYPQLITKPS	PLBD1	116	Q6P4A8
SRYTIKNLLPYRNVH	PTPRU	446	Q92729
LLRTVYSVINRSPHY	GALNT13	131	Q8IUC8
STLLYIRALKNPSHY	HFM1	721	A2PYH4
ASLHQPLYYLLSLLS	OR56A5	56	P0C7T3
LTRHNYVTPKSYLEL	DNAH1	2796	Q9P2D7
KHLPFIYNLSSISIY	GYG1	181	P46976
LPYHVYNIKAIKLSR	DNASE2B	281	Q8WZ79
TQVYRTLHGAYTKIL	DOCK11	1736	Q5JSL3
NKLRRHNYVTPTSYL	DNAH3	2641	Q8TD57
KIYLYTLNDNARSSP	FN1	1971	P02751
GRIYKHSQQPLITYE	FRRS1	336	Q6ZNA5
FAKYQHLPYIQILST	INPP5K	101	Q9BT40
LYNIPSYYSSHALKL	FAM120C	266	Q9NX05
HLTNRVLSLGYATKY	HAS2	316	Q92819
TVVKLAHTYQSPLLY	CENPM	116	Q9NSP4
SSIYYQLNKRLPSTH	DTNB	86	O60941
YPHIVTKLLSRLQFY	ARSB	491	P15848
TKLYSRQGYHLQLQA	FGF13	71	Q92913
KNYQTPDHYTLRKIS	IL20	96	Q9NYY1
YRLEPLILKHYSNIS	DDHD1	666	Q8NEL9
LRRHNYVTPTKYLEL	DNAH2	2971	Q9P225
NINPYKYSTVRHLLA	SCNN1G	101	P51170
PSATHLDQYLYQLRT	DYSF	731	O75923
SPHYILNTRFRKPYN	C8B	201	P07358
LQGKTSYHLVLRAYT	LIFR	801	P42702
YLNISRNLLSTLPKY	LRCH2	161	Q5VUJ6
RLYKPRLASTHVYQI	ITK	576	Q08881
AVVLRQLSPHKYYFL	MRPS24	121	Q96EL2
HYLLSTKQIPGIYNS	SPATA17	166	Q96L03
PRKSNGVITHYNIYL	USH2A	2556	O75445
SRNYLSQPRLTYKTV	ATP6V1B2	36	P21281
IKYHYSSATIPRNLT	TMEM178B	136	H3BS89
LYSHSLLPVDIRQYL	STAT2	21	P52630
LRNPVTNKKHYRLYV	SNRPA1	121	P09661
KVYNLTHLNPSTEYK	LRRN3	576	Q9H3W5
TNHAYIQSLLKRYQP	NODAL	291	Q96S42
YLKNSLVYHPQLRAQ	RHBDL3	196	P58872
TYRAKSHQDYIPVLL	SAMD9L	786	Q8IVG5
SGPYLTHQQKVLRLY	NDUFB9	6	Q9Y6M9
IHTPAKVQLSLYTYL	NBEA	606	Q8NFP9
YLTKPLYTSAPSLQH	SOCS2	151	O14508
QAVQLYYKVFSPTRH	STARD9	4526	Q9P2P6
SRILKHILTQRSYYP	POLA2	496	Q14181
VHRDLKPENLLYYSQ	CAMK1D	141	Q8IU85
ALQILPYTLASLYHR	SLC45A3	391	Q96JT2
PYTLASLYHREKQVF	SLC45A3	396	Q96JT2
LQSLATRLAPIYKQY	TET1	1616	Q8NFU7
PTRLSLVFYQHKNLN	TET1	2041	Q8NFU7
AYSLKYPSRVNHLIL	ABHD5	161	Q8WTS1
EPLRSNLSKYYVLSQ	B3GALT9	61	A8MXE2
YKHTVLVNSERLYLP	TECTA	1176	O75443
HLSYYRNPKLVVTEK	STIL	46	Q15468
YRIQVHPYKSILSEL	XPNPEP1	261	Q9NQW7
LPSTSRRLNHYVLYK	PSMD3	101	O43242
PTLRLNATYYITKQI	REV3L	2976	O60673
PKLPFTQSIYTHYRL	TRAPPC14	346	Q8WVR3
TQSIYTHYRLPSVRL	TRAPPC14	351	Q8WVR3
ESFKQHLLRLQPYLY	TMEM232	186	C9JQI7
HLLRLQPYLYALSFS	TMEM232	191	C9JQI7
RKIYHSSIKPLEQSY	SRL	61	Q86TD4
ESHFPQKYNRLLLYR	SYCP2L	51	Q5T4T6
LQKVSLAPNSRYYLS	SEMA7A	551	O75326
AYIIHLYPSLTLRNL	VPS13C	2661	Q709C8
YVHNLLRISVYFPTL	RRN3P2	201	A6NIE6
PTRISLVFYQHKNLN	TET3	1686	O43151
PRSEHRKYKVLYNSQ	nan	301	Q6ZUG5
RYTLHYKTDAPLNIR	TRAP1	326	Q12931
ILYVLRHYIQKPSSR	UGGT2	211	Q9NYU1
LQNLKPYTKYVLSLH	PTPRC	446	P08575
QLTLSQRKGLNYRYH	TIMP3	126	P35625
SLLRLYQYSNPAVKT	ZBTB40	311	Q9NUA8
VHYQTLRALFQYKPQ	UBASH3A	276	P57075
RNTYKLDLINHPTSY	ZFP69	251	Q49AA0
KYTGRTLNYQSLPHR	USP54	1521	Q70EL1
LSIYSPEHIRQYTNK	MYO7A	111	Q13402
YHYLNQITKKPLRQS	MYO9A	361	B2RTY4